Advanced Filters
noise

Peking, China Clinical Trials

A listing of Peking, China clinical trials actively recruiting patients volunteers.

Found 2,907 clinical trials
S SHEN LIN

A Study in Adults With Desmoid Tumors

This is an open-label, multicenter, single-arm phase 2 clinical study designed to evaluate the efficacy, safety, tolerability, patient-reported outcomes (PROs), pharmacokinetics (PK), anti-drug antibody (ADA) and pharmacodynamics (PD) of ES014 in adult desmoid tumor patients.

18 years of age All Phase 2
D Daihong Liu

EBV-AST Cell Therapy for EBV-Related Diseases After Stem Cell Transplantation

This exploratory clinical study focuses on the use of EBV-AST cell infusion for treating EBV-DNA viremia following allogeneic hematopoietic stem cell transplantation (Allo-HSCT). The study aims to determine the maximum tolerated dose (MTD) or optimal biological dose (OBD) of EBV-AST cells and assess their safety, tolerability, and preliminary efficacy in …

18 - 75 years of age All Phase 1/2
F Feng Duan, MD

TIPS Combined With Lenvatinib and PD-1 Inhibitor for Advanced HCC With Main Trunk PVTT

Hepatocellular carcinoma (HCC) with main trunk portal vein tumor thrombus (PVTT) has poor prognosis. The main lethiferous factor is the upper gastrointestinal hemorrhage by PVTT-related portal hypertension, then the second is the tumor-caused death. It is vital to prevent the portal hypertension by PVTT.

18 - 75 years of age All Phase N/A
X Xu Hui, M.D.

Paclitaxel mIcelle Later-line cOmbined immunoTherapy for Biliary Tract Cancer

After the standard first-line treatment, the treatment regimen was adjusted to a paclitaxel polymer micellar-based immunotherapy combination regimen

18 - 75 years of age All Phase 2
D Dawei Wu, MD, PhD

The Efficacy of Modified Olfactory Training Method for Patients With Post-viral Olfactory Dysfunction

The goal of this clinical trial is to validate the effectiveness of the modified olfactory training device, the main questions it aims to answer are: Is the modified olfactory training device effective in treating patients with post-viral olfactory dysfunction? Compared to the conventional device, how efficient is the modified olfactory …

18 - 80 years of age All Phase N/A
J Jingyang Ma

Pegmolesatide Treatment for Anemia in Patients Undergoing Long-term Dialysis

This study is a prospective, multicenter, parallel-controlled, open-label clinical trial, planned to be conducted across multiple research centers in various provinces and cities in China. It will enroll 240 dialysis-dependent chronic kidney disease (DD-CKD) patients with anemia who have been receiving rHuEPO treatment for at least 4 weeks, with hemoglobin …

18 - 80 years of age All Phase 4
S Shugeng Gao

Perioperative Study of Iparomlimab and Tuvonralimab in Resectable NSCLC

This project intends to study the efficacy and safety of Iparomlimab and Tuvonralimab with or without chemotherapyin the perioperative treatment of NSCLC

18 years of age All Phase 2
J Jian Ren, MD

An Open-Label, Single-Arm Exploratory Clinical Study of Everolimus for the Treatment of Vascular Malformations

This study is a single-arm exploratory trial conducted by Xuanwu Hospital, Capital Medical University, aiming to evaluate the efficacy and safety of everolimus monotherapy in adult patients with vascular malformations.

18 - 65 years of age All Phase 2
H Hong Zhao

Phase II Clinical Study of Leflunomide in the Treatment of MEN-1 Neuroendocrine Tumor

This phase II trial studies aim to evaluate the initial efficacy of leflunomide tablets in second-line treatment of advanced MEN-1 neuroendocrine tumors, and to provide evidence for phase III clinical trials.

18 - 75 years of age All Phase 2

Sedation Efficacy and Safety of Remazolam Besylate in Ventilated Surgical Critically Ill Patients

A multi-center, prospective, randomized, double-blind, no-inferiority clinical trial designed to assess the the safety and efficacy of remazolam besylate in sedation of critically ill mechanically ventilated patients after surgery compared to dexmedetomidine.

18 - 64 years of age All Phase 4

Simplify language using AI